Establishment Labs (NASDAQ:ESTA) Stock Rating Upgraded by Stephens

Establishment Labs (NASDAQ:ESTA) was upgraded by investment analysts at Stephens to a “strong-buy” rating in a report released on Monday,Zacks.com reports.

Several other research firms also recently weighed in on ESTA. JPMorgan Chase & Co. reduced their price objective on shares of Establishment Labs from $61.00 to $50.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Citigroup upped their price objective on shares of Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Finally, BTIG Research upped their price objective on shares of Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, October 14th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $60.60.

Establishment Labs Stock Down 0.6 %

Shares of NASDAQ:ESTA opened at $44.17 on Monday. The firm has a market cap of $1.24 billion, a PE ratio of -17.12 and a beta of 1.16. The company has a fifty day simple moving average of $43.49 and a 200 day simple moving average of $44.55. Establishment Labs has a 12-month low of $22.05 and a 12-month high of $60.12. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94.

Institutional Investors Weigh In On Establishment Labs

A number of institutional investors and hedge funds have recently bought and sold shares of ESTA. Hood River Capital Management LLC acquired a new stake in Establishment Labs during the 2nd quarter worth about $43,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Establishment Labs during the 3rd quarter worth about $127,000. Nkcfo LLC acquired a new stake in Establishment Labs during the 2nd quarter worth about $227,000. SG Americas Securities LLC acquired a new stake in Establishment Labs during the 2nd quarter worth about $303,000. Finally, Black Swift Group LLC acquired a new stake in Establishment Labs during the 3rd quarter worth about $312,000. 72.91% of the stock is owned by institutional investors and hedge funds.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.